Abstract:OBJECTIVE:To explore the effect of OCT4 over-expression on the expression of induced pluripotent stem cell (iPSC)-related transcription factors (cMYC，KLF4，LIN28，NANOG and SOX2) in human bone marrow derived mesenchymal stem cells (hBMMSCs), so as to provide fundamental basis for exploring the pathogenesis of hematological diseases (leukemia, aplastic anemia, etc.) from the perspective of hemopoietic microenvironment in the future.METHODS:Recombinant plasmid pcDNA3.1-OCT4 was constructed and transferred into the optimal generation P3-4 hBMMSCs by liposome transfection. The cells with stable and high expression of OCT4（hBMMSCs-OCT4）were screened by G418 resistance screening (limited dilution) and subcloning, the expression of OCT4 mRNA and OCT4 protein was verified by RT-PCR and FCM, respectively. The expression of iPSC-related transcription factors (cMYC, KLF4, LIN28, NANOG and SOX2) were also determined by FCM and RT-PCR, so as to evaluate the effect of ectopic high expression of OCT4 on the expression of iPSC related transcription factors in hBMMSCs.RESULTS:Recombinant plasmid pcDNA3.1-OCT4 was successfully constructed and cells with stable and high expression of OCT4 were successfully screened from hBMMSCs by limited dilution and subcloning. The result of flow cytometry showed that the mean expression level of OCT4 protein increased from (3.03±1.49)% to (95.46±1.40)% compared with the untransfected parental MSCs, which was also confirmed by RT-PCR analysis. At the same time, the expression levels of OCT4 protein and mRNA were compared between transient transfection (day 4) and stable expression cells (day 96), respectively, it was showed that the OCT4 protein level increased from (36.36±0.28)% at day 4 to (96.25±1.38)% at day 96, and the OCT4 mRNA level increased from 2.75-folds to 6.23-folds, respectively. Compared with the untransfected parental MSCs, the average expression levels of stemness transcription factors increased from (1.12±0.47)% (cMYC), (0.84±0.30)% (KLF4), (2.14±0.79)% (LIN28), (0.63±0.37)% (NANOG) and (14.34±2.44)% (SOX2) to (80.65±4.75)%, (73.03±4.70)%, (68.08±3.05)%, (39.39±1.85)%and (91.45±4.56)% in hBMMSCs-OCT4, respectively, which were consistent with results of RT-PCR analysis. Moreover, the expression levels of NANOG and SOX2 positively correlated with the mean expression of OCT4 (OCT4 vs NANOG: r=0.7802，OCT4 vs SOX2: r=0.4981；NANOG vs SOX2: r=0.7426).CONCLUSION:Cells with stable and high expression of OCT4 have been successfully established from hBMMSCs. Ectopic high expression of transcription factor OCT4 in hBMMSCs can up-regulate the expression of other iPSC-related transcription factors such as cMYC, KLF4, LIN28, NANOG and SOX2.

Comparison of Human Induced Pluripotent Stem Cells and Oct4/Nanog Gene Expression in Human Embryonic Stem Cell Differentiation

Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression Signatures

Comparison of the differentiation capability between human parthenogenetic embryonic stem cells and normal embryonic stem cells

Directed Neuronal Differentiation of Mouse Embryonic and Induced Pluripotent Stem Cells and Their Gene Expression Profiles

Neural Differentiation of Human Induced Pluripotent Stem Cells Follows Developmental Principles but with Variable Potency

[Effect of OCT4 Gene Expression Upregulation on the Expression of Ipsc-Related Transcription Factors in Human Bone Marrow Derived Mesenchymal Stem Cells].

Comparative transcriptomic analysis identifies reprogramming and differentiation genes differentially expressed in UiPSCs and ESCs

Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells

Residual Undifferentiated Cells During Embryoid Bodies Differentiation of Induced Pluripotent Stem Cells

Functional Modules Distinguish Human Induced Pluripotent Stem Cells from Embryonic Stem Cells

The gene expression profiles of induced pluripotent stem cells (iPSCs) generated by a non-integrating method are more similar to embryonic stem cells than those of iPSCs generated by an integrating method.

Expression of embryonic stem cell-related transcription factors in human umbilical cord mesenchymal stem cells

Introduction of OCT4 into Human Bone-Marrow Derived Mesenchymal Stromal Cells Generates Putative Ips Cells with the Potential to Differentiate into CD34+ Hematopoietic Progenitor Cells Ex Vivo

Comparative study of periodontal differentiation propensity of induced pluripotent stem cells from different tissue origins.

Transcriptomic and Epigenomic Resemblance of Terminally Differentiated Cells Derived from Isogenic Human Ipscs and Nuclear Transfer Derived Escs

Estimating the Quality of Reprogrammed Cells Using ES Cell Differentiation Expression Patterns

The comparison of human embryonic stem cells cultured in feeder-containing culture system and feeder-free culture system

Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells

Functional Characterization and Expression Profiling of Human Induced Pluripotent Stem Cell- and Embryonic Stem Cell-Derived Endothelial Cells

Progress regarding induction of pluripotent stem cells

Comparative analysis of naive, primed and ground state pluripotency in mouse embryonic stem cells originating from the same genetic background